Transport Pharmaceuticals Device/Drug Combo For Herpes To Launch In 2007
This article was originally published in The Gray Sheet
Executive SummaryTransport Pharmaceuticals expects to file a 510(k) by early 2007 for a device/drug combination system that treats oral herpes in a single, 10-minute application
You may also be interested in...
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.